ON-DEMAND WEBINAR
De-Risking Gene Therapy Development: Stress Testing Viral Vectors with Mass Photometry Analysis
Presenter: Hena Divanovic, Applications Scientist
Viral vectors are the backbone of life-saving cell and gene therapies. Yet, adeno-associated virus (AAV) and lentiviral vectors (LVV) differ significantly in their structural properties, leading to distinct behaviors under environmental stress. When it comes to monitoring these stress responses, traditional analytical techniques often fall short. They’re complex, resource-intensive, and lack the resolution to assess vector integrity and heterogeneity at the single-particle level.
In this on-demand webinar, Hena Divanovic explores how mass photometry transforms this process by providing a high-resolution, single-particle approach to:
- Optimize process development
- Assess vector integrity
- Mitigate risks in gene therapy development with fast, at-line analytics
What You’ll Learn:
- Why AAV and LVV respond differently under stress—and why it matters
- How mass photometry enables rapid, precise characterization of viral vectors
- Strategies to identify process vulnerabilities and build more robust therapies
Watch now to explore cutting-edge strategies for de-risking gene therapy development.